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Abstract
Multisystemic disorders represent a heterogenous group of diseases
which can primarily manifest at the nose and paranasal sinuses as
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limiteddiseaseorsecondarilyaspartofsystemicinvolvement.Rhinolo-
gists therefore play an important role in the diagnostic but also thera-
peutic process. Although therapy of multisystemic disorders is primary 1 University of Münster,
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duct, septorhinoplasty and closure of nasal septal perforation. Since
theprevalenceofmostsystemicdiseasesisveryrare,recommendations
are based on the analysis of single case reports and case series with
a limited number of patients only. Although data is still limited, experi-
ences published so far have shown that autologous cartilage or bone
grafts can be used in nasal reconstruction of deformities caused by
tuberculosis, leprosy, Wegener’s granulomatosis, sarcoidosis and re-
lapsingpolychondritis.Experiencesgainedfromthesediseasessupport
the concept that well-established techniques of septorhinoplasty can
be used in systemic diseases as well. However, a state of remission is
an essential condition before considering any rhinosurgery in these
patients. Even under these circumstances revision surgery has to be
expected more frequently compared to the typical collective of patients
undergoing septorhinoplasty. In addition, experiences gained from
saddle nose reconstruction may in part be of value for the treatment
of nasal septal perforations since implantation of cartilage grafts often
represents an essential step in multilayer techniques of closure of
nasal septal perforations. Aside from the treatment of orbital compli-
cations sinus surgery has been proven beneficial in reducing nasal
symptomsandincreasingqualityoflifeinpatientsrefractorytosystemic
treatment.
Keywords: systemic disorder, rhinoplasty, nasal septal perforation,
saddle nose, sinusitis
1 Introduction
Systemic disorders represent a heterogenous group of
diseases which can primarily manifest at the nose and
paranasal sinuses as limited disease or secondarily as
part of the systemic involvement. In general, therapy is
systemic but often requires a multidisciplinary approach
withparticipationofseveraldifferentspecialists.Therole
of the rhinologist is very important since she/he may
discover a multisystemic disease at an early stage when
the disease is still localized. In this case, early systemic
therapy can ideally prevent or at least diminish fatal or-
ganic damage. In addition, systemic therapy is usually
essential before rhinosurgery is intended. This review
provides a selection of systemic diseases with nasal
manifestations and their rhinosurgical options of treat-
ment. Because of the rare prevalence of most of the dis-
easesrecommendationsaremainlybasedontheanalysis
ofsinglecasereportsorcaseserieswithalimitednumber
of patients. Provided that rhinosurgical techniques have
been reported for a specific disease, they are described
and discussed at the corresponding section.
2 Infectious diseases
2.1 Tuberculosis
Epidemiology/pathogenesis: Even today tuberculosis is
still one of the most frequent infectious diseases world-
wide. According the German Robert Koch institute (RKI)
in 2007 the incidence of tuberculosis in Germany was
6.1/100,000. In most cases the disease is caused by
Mycobacteriumtuberculosis.Tuberculosisoftencoincides
with HIV or AIDS. Clinically, primary nasal involvement
can be distinguished from secondary involvement as a
result of pulmonary tuberculosis. The diagnosis of nasal
tuberculosis is based on medical history, nasal endo-
scopy, histological evidence of typical tubercular granu-
lomainthenasalmucosa,PCR-detectionofmycobacterial
DNA and cultivation of Mycobacterium tuberculosis from
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with predominance in females [1], [2], [3].
Nasal symptoms: Symptoms are in general non-specific
and include obstructive and rhinitis-like complaints, epi-
staxis and crusting. Suspicious findings such as easily
bleeding membranes and crusts may be observed at the
anterior part of the cartilaginous septum and at the in-
ferior turbinates [3], [4]. Nasal septal perforation can
occur as a first symptom of the disease [5]. Involvement
of the sinuses and nasopharynx has been reported [6],
[7], [8]. Recently, we ourselves could observe all these
findings in a patient with nasopharyngeal tuberculosis
(Figure1).Nasalpolypsmaybeobservedaswellinthose
patients and are considered suspicious for nasal tuber-
culosis when originating from the inferior turbinates [9],
[10].
Figure 1: Nasal tuberculosis. Region of the nasal choanae (C).
Easily-bleedingmembranesarevisibleinthenasopharynxand
at the dorsal septum (S).
Rhinosurgery: Asidefrommucosalinvolvementthenasal
skin may be involved as well. Such cutaneous manifest-
ations of tuberculosis are designated “Lupus vulgaris”.
Ithasbeenreportedthatinvasionatthemucocutaneous
junction, nasal vestibulum and dorsal nasal skin can
resultinfissuresandcontracturesofthenasalcartilages
[11]. Aftera6-monthscourseofsystemictherapy, recon-
structive rhinosurgery was performed using an auricular
composite graft [3].
Sinus surgery may be indicated in patients with involve-
ment of the sinuses refractory to systemic treatment. To
our knowledge the indication for closure of nasal septal
perforations due to nasal tuberculosis has not been dis-
cussed in the literature so far. However, following a suc-
cessfulcourseof12-monthssystemictherapywithunsus-
piciousclinicalandnegativemicrobialfindingsconditions
forclosureofnasalseptalperforationsseemtobeaccept-
able.
2.2 Leprosy
Epidemiology/pathogenesis:Leprosy(Hansen’sdisease)
isaninfectiousdiseasecausedby Mycobacteriumleprae
and involves the skin, mucosal surfaces and peripheral
nerves. Although it is a very rare disease in Europe, lep-
rosystillbelongstothemostfrequentinfectiousdiseases
worldwide with an annual incidence of 250,000 new
cases. Clinically, five subtypes can be distinguished due
to the patient’s immune status, clinical and histological
findings. In addition, PCR diagnostic may be useful [12].
Nasal symptoms: In general, early stages are character-
ized by unspecific nasal symptoms with the exception of
a reduced sense of smell [13]. Sinonasal symptoms can
occur and can be refractory to systemic treatment [14],
[15].Theclinicalspectrumrangesfromlocalizedinvolve-
ment of the external nose and extensive destruction of
the septal cartilage and bone resulting in nasal septal
perforation and saddle nose deformity [16], [17], [18].
Moreover, destruction of the anterior nasal spine and of
nasal turbinates is not uncommon. Thus, the degree of
destruction is often more extensive compared with other
systemic diseases discussed in this review. In severe
cases only the nasal skin and he lower lateral cartilages
arepreserved[18].Principally,systemictreatmentshould
precede any local surgical procedure.
Rhinosurgery: Menger and coworkers reconstructed 24
saddle nose deformities of different severity caused by
leprosy [18]. In all cases an external approach was used.
A V-Y procedure was used in four patients in order to
lengthen a retracted columella. The nasal septum and
upper lateral cartilages were reconstructed by implanta-
tionofadorsalonlaygraft.Anabsentanteriornasalspine
wasreconstructedbyimplantationofacaudallyextended
columella strut. The authors exclusively used autologous
costalandauricularcartilage.Woundinfection,extrusion
or warping of implants was not observed in any patient.
Functional and aesthetic improvement was observed in
15/17 patients. The rate of implant resorption was de-
pendent on the implant site. Least resorption was ob-
servedfordorsalonlaygrafts(4/17).Moderateresorption
wasobservedforcolumellastrutandshieldgrafts(7/17).
In general, conchal cartilage grafts were associated with
less resorption than costal cartilage grafts. Overall, ad-
vantages are dominating so that the authors advocate
reconstructionofsaddlenosedeformitiesinleprosyusing
autologous cartilage grafts [18]. Aside from cartilage
grafts bone grafts have been used by another group.
However, the rate of complications such as wound infec-
tion and graft resoprtion was 50% [19].
3 Immune deficiency
Immune deficiency can be broadly classified in primary
immune deficiency syndromes that are very rare and
thoseacquiredsecondarilyduringlife.Asaconsequence,
these patients may suffer from opportunistic bacterial,
viral, fungal or parasite infections. At the nose and the
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Sachse et al.: Nasal surgery in patients with systemic disordersFigure 2: Closure of a small nasal septal perforation (type A) in a HIV positive patient by cartilage exchange. Demonstration of
the small perforation (A). Cartilage resection at the borders of the perforation (B, C). Dorsal septal cartilage graft (D). Closed
perforation (E).
sinuses infections generally manifest as acute/chronic
sinusitisornasalseptalperforation.Asalreadymentioned
numerous diseases may be associated with an immuno-
suppressed condition. As an example we discuss the im-
pactofimmunesuppressionandtheroleofrhinosurgery
in patients with HIV/AIDS and primary nasal NK/T-cell
lymphoma.
3.1 HIV/AIDS
Epidemiology/pathogenesis:AccordingtotheRKI3,000
new infections per year have been observed in Germany
since 2007. Causative pathogens are several types of
the human immune deficiency virus (HIV).
Nasalsymptoms:Rhinitis-likesymptomcanbeobserved
frequentlyinthisgroupofpatients.Porterandcoworkers
interviewed HIV positive patients and found sinonasal
symptoms in 66% of cases. Sinusitis was reported by
54% of patients. Allergic rhinitis like symptoms were re-
portedby80%ofpatients[20].Similarobservationswere
reported by Prasad and coworkers who investigated
sinonasal symptoms in 968 HIV positive patients. They
found that sinusitis complaints were predominating in
their patients [21].
Aside from bacterial sinusitis invasive fungal sinusitis is
aseriousthreatforimmunosuppressedpatients.Therapy
hastobeinitializedimmediatelyandconsistsofextensive
surgical removal of involved tissue and application of
Amphotericin B [22], [23]. Nasal septal perforations as-
sociatedwithinvasivefungalsinusitishavebeenreported
[24].
Rhinosurgery: Functional endoscopic sinus surgery can
reducesymptomsinHIVpositivepatientswiththeexcep-
tion of improvement of a reduced sense of smell [25],
[26].Nasalseptalperforationshavebeenrarelyobserved
butmaybethefirstsymptomofthedisease.Sometimes,
the cause of a nasal septal perforation can be identified.
Bennettandcoworkersdetected Mykobakteriumkansasii
in a HIV positive patient with nasal septal perforation
[27]. Prior to any rhinosurgery, HIV positive patients and
those suffering from AIDS require long-term stabilisation
oftheirimmunesystemandstrictcontrolofopportunistic
infections. Only in this situation closure of a nasal septal
perforation should be planned [27], [28]. In the past,
mortality of AIDS was tremendously higher than today.
That is why rhinosurgery was contraindicated or had less
priority in these patients. We ourselves have closed a
small perforation in a HIV positive patient using an auto-
logous septal cartilage graft combined with bilateral mo-
bilisation of mucosal flaps (Figure 2).
3.2 Primary nasal NK/T-cell-lymphoma
Epidemiology/pathogenesis: Immunophenotyping and
modern moleculargenetic studies revealed that destruc-
tive midline lesions actually represent manifestations of
sinonasal Non-Hodgkin lymphomas of the type “Primary
nasalNK(naturalkillercell)/T-celllymphoma”ordestruc-
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[30], [31]. An association of Epstein-Barr-Virus with
primary nasal NK/T-cell lymphoma has been reported
[32], [33]. The incidence for western Europe and the
United States has been estimated to be below one per-
cent per year [34].
Nasal symptoms: Locally NK/T-cell lymphoma initially
presents with unspecific symptoms including nasal ob-
struction, purulent rhinorrhea, epistaxis, crusting and
local inflammation of the nose and face and sometimes
ophthalmologiccomplaints.Diseaseprogressionisasso-
ciated with mucosal ulceration, nasal septal perforation
and destruction of the hard palate formerly summarized
by the clinical term “lethal midline granuloma”. Dissem-
inated disease is characterized by metastasis into the
skin,visceralorgans,andgeneralillnessandbysocalled
B-symptoms.AgressiveNK/T-cellleukaemiaisassociated
with very fast disease progression and lethal outcome.
Therapy of NK/T-cell lymphoma is dependent on tumor
stage as defined by the Ann-Arbor classification. For
stagesIandIIradiotherapyaloneisthetherapyofchoice.
Chemotherapy and chemotherapy combined with radio-
therapy are options for progressive tumor disease. The
5-year survival rate for stages I and II does not exceed
50%. Disease progression is associated with lethal out-
comewithinweeksorevendaysinthecaseofaleukaem-
ic course of disease [29], [35].
Rhinosurgery: Because the prognosis of primary nasal
NK/T-cell lymphoma is very poor, rhinosurgery has just
low priority and may be considered in a persistent state
of remission. At any rate, local wound healing would
probably be impaired following radiotherapy. In the case
ofextensivedestructionofthenose,hardpalate,sinuses
andfaceprostheticrehabilitationis analternative option
for these patients [36].
4 Multisystemic diseases
4.1 ANCA associated vasculitis
The term “ANCA associated vasculitis” summarizes We-
gener’s granulomatosis, microscopic polyangitis and
Churg-Strauss Syndrome because these diseases share
some clinical, pathogenetic and immunologic findings.
In general, this group of vasculitis involves small vessels
(small vessel vasculitis).
4.1.1 Wegener’s granulomatosis
Epidemiology/pathogenesis:Wegener’sgranulomatosis
(WG) is characterized by granulomatous inflammation of
the respiratory tract, necrotizing vasculitis of the small-
and medium-sized vessels and by necrotizing glomer-
ulonephritis [37]. The disease usually begins not before
the fourth decade of life. An annual incidence of
10/1,000,000 in Germany has been reported [38].
Classically the upper respiratory tract, the lungs and the
kidneys are involved. However, localized WG has been
observed in 10–15% of patients presenting with head
and neck involvement only [39].
ThediagnosisofWGcanbemadeaccordingtothecriteria
of the American College of Rheumatology (ACR) [40].
Nasaltissuebiopsiesrevealtypicalhistopathologicsigns
ofWGinthemajorityofpatients[41].Serologicdetection
of antineutrophil cytoplasmatic antibodies with cytoplas-
matic fluorescence (cANCA) and ELISA (Enzyme-linked
Immunosorbent Assay) reactivity against proteinase 3
(anti-PR3) is an important finding in WG. In addition, it
has been observed that superantigens derived from
Staphylococcusaureusareassociatedwiththeproduction
of PR3-ANCA [42]. Clinically, colonization of the nasal
mucosa by Staphylococcus aureus is considered as a
risk factor for relapse [43]. There is much variability of
the spectrum of systemic manifestations as musculo-
skeletal, neurologic and skin manifestation can occur,
too. Although renal manifestations are rarely observed
initially, 75% of patients have renal involvement during
disease progression [44].
Nasal symptoms: In the head and neck region WG can
manifest with sinonasal, auricular, laryngotracheal, oph-
thalmologic and/or salivary gland complaints. In the
generalized phase the nose and the sinuses display the
highest degree of disease activity [45], [46]. Mucosal
edema, granulation and massive crusting are typical
findingsforWG(Figure3).Sometimes,amucosalpattern
of cobblestoning can be observed [47]. The anterior part
of the nasal septum (Kiesselbach’s area) is one of the
mostfrequentlyinvolvedareas.Withdiseaseprogression
mucosal erosions and formation of scars may be visible.
Finally, extended disease may present with nasal septal
perforation or saddle nose deformity [41], [48]. Nasal
endoscopy is important since it has been reported that
diseaseactivitycanbeevaluatedbytheinspectionofthe
nasal mucosa [49].
Figure 3: Active Wegener’s granulomatosis. Massive crusting
and inflammation of the nasal mucosa.
RasmussenaswellasCannadyandcoworkersexamined
patients with WG and evaluated nasal symptoms. Nasal
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Sachse et al.: Nasal surgery in patients with systemic disordersFigure 4: Wegener’s granulomatosis in remission. Large nasal septal perforation (type C). No signs for inflammation or crusting
are visible (A). Closure of the perforation by (bilateral) inferior turbinate flap (B) and costal cartilage interposition graft (not
shown).
obstruction was reported by 54–58% of patients, recur-
rentepistaxisandfoetorby50–52%ofpatients,massive
crusting by 56–69% and sinonasal involvement by
33–61% of patients [50], [51]. According to Cannady the
frequencyofanasalseptalperforationwas33%and28%
for saddle nose deformity. The rate of ophthalmologic
symptoms such as epiphora and pseudotumor orbitae
are 13% and 3% respectively [50].
Rhinosurgery: Rhinosurgery in WG aims to eliminate or
atleastreducecomplaintscausedbynasalseptalperfor-
ation or saddle nose deformity. Surgery should be per-
formedonlyifremission(ideallycompleteremission)was
achieved or a minimum of disease activity is left [45],
[52], [53]. Perioperative induced flare ups of disease
activity and impaired wound healing are considerations
that may argue against an operation.
Frequently, structural cartilaginous and mucosal defects
can be observed in WG. To solve this problem Duffy and
coworkers have suggested a technique using bilateral
facial artery based musculomucosal flaps [54]. Recently
Congdong and coworkers published a series of cases of
WGpatientsundergoingreconstructiverhinosurgeryand
analyzed the long-term follow up. Twelve saddle nose
deformitieswerecorrectedinastateofstableremission.
Two patients required revision rhinoplasty (primary suc-
cessrate77%,overallsuccessrate92%).Forreconstruc-
tions costal cartilage (39%) and temporoparietal bone
(calvarialbonegraft,26%)wereimplantedinthemajority
of cases. In addition, irradiated allogenous rib (7%), irra-
diateddura(7%),autologousconchalcartilage(7%),iliac
crest (7%) and bony septum (7%) were used. In one case
anauricularcompositegraftwasusedforthereconstruc-
tion of an ala rim defect. Nishiike and coworkers recon-
structed a saddle nose deformity using autologous iliac
crest [55].
As evaluated by Congdon and coworkers rhinosurgery
doesnotinduceaflare-upnordoesitinfluencethecourse
ofthedisease.However, diseaseseveritycontributesthe
success rate in saddle nose reconstruction due to the
observationthatpatientswithlocalizedWGhadanoverall
success rate of 88% whereas those with involvement of
thelungshadjust60%.Itisworthtomentionthatresorp-
tion was always observed with irradiated materials
(transplant success rate: 0%), whereas least resorption
was seen for autologous transplants(transplantsuccess
rate costal cartilage: 83%/calvarial bone graft: 75%).
Overall, saddle nose reconstruction in patients with WG
is safe even if an increased rate of revision surgery has
to be expected compared with a typical collective of
septorhinoplasty [53].
Shipchandler and coworkers reconstructed four saddle
nose deformities using an external rhinoplasty approach
by implantation of a split calvarial bone L-shaped strut.
This L-shaped strut consisted of a dorsal onlay graft and
a columella strut fixed together with a titan screw. The
strut was placed in a subcutaneous pocket under the
skin of the nasal dorsum and fixed between the medial
crura of the alar cartilages. Wound infection, extrusion
ordislocationoftransplantsdidnotoccur.Duringafollow-
up period of 21 months no resorption of transplants was
observed [56].
Closure of nasal septal perforations in WG has been
traditionally refused or considered as contraindication
since the chronic course of the disease and flare-ups
prevent successful wound healing. In addition perfora-
tions are often very large [51], [52]. However, we have
successfully closed a large nasal septal perforation in a
WG patient in remission and well-cared nasal mucosa.
Closure was achieved by bilateral mobilization of inferior
turbinate pedicled mucosal flaps and interposition of
costalcartilage(Figure4).Inthecaseofpersistentactive
disease or failed closure of a perforation implantation of
a septal button is an alternative option of treatment.
Functional sinus surgery including decompression of the
orbit and the optical nerve may become necessary for
some patients although data are very limited so far [50],
[55], [57]. Furthermore, patients with involvement of the
nasolacrimal duct may require drainage surgery [50],
[58], [59].
4.1.2 Microscopic polyangiitis
Epidemiology/pathogenesis: Microscopic polyangiitis
(MPA) is a necrotizing vasculitis characterized by low or
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vessels (necrotizing glomerulonephritis, pulmonary ca-
pillaritis).Involvementofmediumsizedarterieshasbeen
observed, too. Further definition criteria do not exist.
Distinction from panarteriitis nodosa has been made
for a few years only [37]. An annual incidence of
3/1,000,000 in Germany has been reported [60]. Anti-
neutrophilanticytoplasmaticantibodieswithaperinuclear
fluorescence pattern (pANCA) that are directed against
myeloperoxidase(anti-MPO)canbedetectedinMPA.The
diagnostic golden standard still is histological evidence
preferentially gained by renal biopsy. Nasal biopsy is
usuallyunsuccessful[41].Systemictherapyisanalogous
to that of WG [61].
Nasal symptoms: In general, sinonasal manifestation of
polyarteriitis nodosa and MPA are very rare. According to
the studies of Paulsen and Rudert only Rhinosinusitis
with crusting may be considered a frequent symptom
[41]. Metaxaris and coworkers found nasal symptoms
such as epistaxis and sinusitis in 8/18 patients [62]. We
ourselves have observed bilateral prominent vessels at
the Kiesselbacharea in a patient with MPA who reported
frequent episodes of epistaxis (Figure 5). Interestingly,
this area is predominantly involved in WG, too. Nasal
polypsandnasalseptalperforationhavebeenobserved,
whereas to our knowledge saddle nose deformities have
not been reported so far [41], [63], [64], [65], [66].
Figure 5: Microscopic Polyangiitis. Prominent vessels at the
area II in a patient suffering from recurrent episodes of
epsitaxis.
Rhinosurgery: Because of a similar pathophysiology
treatment should orientate on WG.
4.1.3 Churg-Strauss Syndrome
Epidemiology/pathogenesis: Churg-Strauss-Syndrome
(CSS) was described for the first time in 1951 by Churg
and Strauss as allergic angiitis and allergic granulo-
matosis.Anannualincidenceof1/1,000,000inGermany
has been estimated [67]. Diagnosis of CSS can be made
according to the criteria suggested by the American Col-
legeofRheumatology(ACR)oraccordingtothedefinition
of the Chapel Hill Consenus Conference [37], [68].
The typical histopathological finding of eosinophilic vas-
culitis and the association with asthma allow distinction
from other types of vasculitis. However, histopathologic
evidence gained from a nasal biopsy is rarely successful
[41]. Hypereosinophilia (>1,500/µl) and detection of
pANCA directed against MPO are suspicious of CSS.
Nasal symptoms: Sinonasal symptoms are frequently
observed in CSS patients. Actually, one third of patients
with CSS consult an Otorhinolaryngologist because of
worsening of nasal complaints. Symptoms associated
withallergicrhinitissuchasobstruction(95%),rhinorrhea
(95%), anosmia(90%) and excessive sneezing(80%) are
predominantinthesepatients.Somepatientssufferfrom
a milder degree of nasal crusting (75%) and purulent
(65%) or bloody (60%) rhinorrhea thereby sharing some
symptoms also observed in WG [69]. Nasal polyps may
be present in up to 76% of patients [70], [71], [72].
Nasal septal perforation has been observed in CSS [41],
whereassaddlenosedeformitieshavenotbeenreported.
Rhinosurgery: Because of a similar pathophysiology
treatment should orientate on WG.
4.2 Sarcoidosis
Epidemiology/pathogenesis: Sarcoidosis (Boeck’s dis-
ease) is a chronic multisystemic disorder of unknown
aetiologyaffectingpredominantlyyoungadultsandpeople
of middle age. An annual incidence of 10/100,000 has
been estimated [73]. Bilateral hilar lymphadenopathy
and increased levels of the Angiotensin converting en-
zyme (ACE) are suspicious of sarcoidosis. The most im-
portanthistopathologicsignisnon-caseatinggranuloma.
Moreover, cervical lymphadenopathy, salivary gland and
lacrimal gland hypertrophy, Lupus pernio and ophthal-
mologic complaints are observed in these patients.
Sinonasal involvement can occur as part of systemic
disease but can also represent limited disease of the
nose and sinuses [74].
Zeitlin and coworkers analyzed 733 cases of sarcoidosis
and found that sinonasal involvement often is underes-
timated.Interestingly,patientswithsinonasalinvolvement
frequently required prolonged systemic therapy [75]. In
order to standardize the diagnosis of sinonasal sarcoid-
osis de Shazo and coworkers have developed a number
of criteria [76].
Nasal symptoms: Sinonasal sarcoidosis often presents
with unspecific symptoms such as nasal obstruction,
crusting, epistaxis, postnasal drip, recurrent episodes of
sinusitis,facialpainandheadache.However,endoscopic
examination typically reveals a hyperplastic and friable
mucosa with reddish and edematous areas. In addition,
small yellowish nodules in the submucosa of the nasal
septum and the inferior turbinates are considered suspi-
cious for sarcoidosis [77]. Hyposmia or even anosmia
can represent further symptoms of the disease. In add-
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phymmaybeassociatedwithsarcoidosis.Arrosionofthe
soft and hard palate due to destructive granuloma as
well as saddle nose deformity have been reported [78],
[79]. Cranial base involvement and intracranial spread
aswellasinvovlementofthenasolacrimalducthasbeen
observed [80], [81]. Small nodular skin lesions of the
nasal ala regions have been reported [82].
Rhinosurgery: Although glucocorticosteroids represent
the first choice of drugs in the treatment of sarcoidosis,
functional endoscopic sinus surgery has been shown to
relief symptoms, to reduce the amount of glucocortico-
steroids and to improve quality of life in a group of pa-
tients [74], [83], [84]. Kay and coworkers retrospectively
analyzed a collective of 86 patients with sinonasal sar-
coidosis. Six of their patients (7%) underwent sinus sur-
gery because of anatomic blockage of the osteomeatal
complex due to recurrent acute epsidodes of sinusitis,
polyp formation or granuloma [83]. Similar observations
were reported by Goodmann and coworkers who per-
formed sinus surgery in six patients with refractory
sinonasal sarcoidosis [84]. Correspondingly, Zeitlin and
coworkers advocate rhinosurgery in patients refractory
tosystemictreatment[75].Almostnodataexistconcern-
ing saddle nose reconstruction in patients with sarcoid-
osis. Shipchandler and coworkers used a L-shaped cal-
varial bone graft for saddle nose reconstruction in one
patient [56].
4.3 Relapsing polychondritis
Epidemiology/pathogenesis: Relasping polychondritis
(RP) is a very rare rheumatologic disease characterized
by recurrent inflammation and destruction of auricular
and nasal cartilages. In addition, the disease may also
involve joints, eyes, the audiovestibular system, the car-
diovascular system and the respiratory tract. An auto-
immune pathogenesis seems possible since antibodies
directed against type II collagen have been detected in
cartilages.Anannualincidenceof1/3,500,000hasbeen
estimated [85].
The clinical picture is rather variable and may present as
auricularchondritis,nasalchondritis/saddlenosedeform-
ity,laryngotrachealchondritiswithcollapseofthetracheal
airway or tracheal stenosis, audiovestibular symptoms,
inflammation of ocular structures or polyarthritis or as a
combination of these symptoms. The diagnosis can be
made according to the criteria defined by McAdam [86]
or by Damiani and Levine [87].
Nasal symptoms: Nasal chondritis resembles auricular
chondritis in that both often occur acute and are very
painful. In addition, nasal fullness of the nose reported
as well as epistaxis and rhinorrhea. Following several re-
currentepisodesofnasalchondritissaddlenosedeform-
ity can be the final result.
Rhinosurgery: Rhinosurgery in RP is based on a limited
number of case reports only. Rapini refused reconstruc-
tion of saddle nose deformities in RP because of the re-
lapsing character of the disease [88]. By contrast, Haug
and coworkers successfully reconstructed a saddle nose
using iliac crest.A bony implant was chosenbecausethe
authorsconsidereditmoreresistantandlessresorpable
compared with cartilage [89]. Torossian and coworkers
reconstructedasaddlenosedeformityinayoungpatient
using calvarial bone graft. The operation was performed
12 months after establishing the diagnosis of RP and in
a state of stable remission [90]. Experiencesreported by
Bellandcoworkersargueagainstatheoreticalsuperiority
of bone implants. Usage of cartilage implants is possible
in RP if relapsing episodes of nasal chondritis are pre-
vented or reduced to a minimum by immunosuppressive
therapy. Bell and coworkers used autologous costal car-
tilagetoreconstructasaddlenosein14yearsoldpatient.
Although two more episodes of chondritis occurred no
signs of resorption of the cartilaginous implant was ob-
served one year after the operation [91].
4.4 Systemic Lupus erythematosus
Epidemiology/pathogenesis: Systemic Lupus erythema-
tosus (SLE) is an autoimmune disorder with potential
manifestations at nearly all organs and tissues of the
humanbody.Thediseasepredominantlyinvolvesfemales.
An annualincidenceof 5/100,000 in Germany has been
reported [92]. Oral and nasopharyngeal ulceration are
considered as diagnostic criteria for SLE [93].
Nasal symptoms: Nasal symptoms are generally unspe-
cificsuchasmildepisodesofepistaxisorlocaltenderness
or facial pain. The nasal mucosa may appear diffusely
reddish and edematous or as atrophic rhinitis. Less than
70 cases of nasal septal perforation have been reported
so far worldwide. Nasal septal perforation is even more
rarelyobservedasafirstsymptom[94].Inaretrospective
study of the lupus clinic of the University of Toronto nasal
septal perforation was discovered in 40/885 (4.6%)
patients with SLE. These perforations usually remain
asymptomatic since they are detected after a course of
6.1 years in the mean. In addition, nasal septal perfora-
tions occur during exacerbation of the disease or in the
context of vasculitis [95]. Oral ulceration often precedes
nasal septal perforation.
5 Inflammatory bowel disease
5.1 Crohn’s disease
Epidemiology/pathogenesis: Crohn’s disease (CD) is an
inflammatory bowel disease and can involve all parts
of the gastrointestinal tract. An annual incidence of
5.2/100,000 in Germany has been reported [96]. Histo-
pathologyrevealsnon-caseatinggranulomaasavaluable
diagnostic sign that however is detectable in 10% of the
cases only. Extraintestinal spread has been observed.
Aside from the oral cavity, the nose and the larynx may
be involved in the head and neck region [97], [98], [99].
Nasal involvement is extremely rare since less than 15
cases have been reported throughout the world so far
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[107].
Nasal symptoms: The spectrum of nasal symptoms con-
sistsofnasalobstruction,rhinorrhea,hyposmia,epistaxis
and complaints of sinusitis. The nasal mucosa may ap-
pear diffusely reddish and hypertrophic and easily starts
bleeding. Erosion, ulceration and necrosis of the septum
or inferior turbinates may be visible [100], [101], [106],
[107], [108]. In addition, nasal septal perforation and
saddle nose deformity have been reported [104], [109],
[110]. It is worth to mention that nasal symptoms may
precedegastrointestinalsymptoms[111].Anassociation
withWGandRPhasbeenobserved.Bookandcoworkers
retrospectively analyzed 160 patients suffering from in-
flammatory bowel disease. They observed chronic sinus-
itis particularly in those CD patients (23%) who suffered
from obstructive bowel complications, whereas rhino-
sinusitis was observed only in 7% of patients without ob-
structive bowel complications [99].
Rhinosurgery: Toourknowledgereconstructionofsaddle
nose deformities or closure of nasal septal perforations
has not been discussed in the literature so far. Partial
turbinate resection has been reported [108]. Sinus sur-
gery may become necessary to reduce sinonasal symp-
toms and to control orbital complications [107].
5.2 Ulcerative colitis
Epidemiology/pathogenesis: Aside from CD ulcerative
colitis (UC) belongs to the group of inflammatory bowel
disease. An annual incidence of 6/100,000 in Germany
has been reported [112]. Although aetiology of UC still
remainsunclear,anautoimmunepathogenesishasbeen
suggested. An association of UC with chronic sinusitis
has been hypothesized in some patients [113].
Nasal symptoms: Nasal septal perforation is a rarity
[114].
6 Heriditary hemorrhagic
telangiectasia
Epidemiology/pathogenesis:Heriditaryhemorrhagictel-
angiectasia (HHT, Osler’s disease) is an autosomal dom-
inant-disease of angiogenesis. The underlying genetic
aberrationsareassociatedwithformationofendothelial-
lined vascular lakes and dilatated vessels. Because the
vessel’s wall structure is abnormal due to the lack of
muscular or elastic support rupture of these vessels
alreadyoccursbysmalltrauma.Thiscanleadtosubstan-
tial bleeding although coagulation factors and platelets
are normal because pathologic vessels do not retract or
undergovasospasm.Currently,anincidenceof1/10,000
has been reported [115].
Nasal symptoms: Quality of life is of HHT patients is
mainly determined by recurrent episodes of epistaxis
[116], [117], although arteriovenous malformations of
the gastrointestinal tract, lungs, liver and brain are often
associated with higher morbidity and mortality [118]. A
variety of treatment options to control epistaxis in HHT
patients are available. These include topical therapies,
hormonal therapies with estrogens, laser coagulation as
well as argon-plasma coagulation [115], [119], [120],
[121], [122]. Argon-plasma coagulation, bipolare coagu-
lation as well as anterior and/or posterior nasal packing
represent procedures to control acute episodes of epi-
staxis.Severeepistaxiscanbecontrolledbyinterventional
radiologicalembolization[123],[124]andsurgicalarter-
ial ligation [125].
Rhinosurgery: Recently, new data have been published
analyzing long-term results and quality of life in HHT pa-
tients treated by septodermoplasty or nasal closure.
Septodermoplasty
Themainprincipleofseptodermoplasty(SDP)isresection
ofdiseasedmucosaofseptalareasIIandIIIandimplant-
ationofanepidermalgraft.Eliminationofeasilybleeding
mucosal areas leads to a reduction of the frequency of
bleeding within the first two years. After two years how-
ever, new formation of telangiectatic vessels dorsal to
theepidermalgraftisoftenobserved.Asaconsequence,
the frequency of bleeding increases again. Moreover,
access to the bleeding vessel then is usually difficult.
These arguments have been considered as major points
of criticism of this method.
By contrast, recently published studies emphasize the
benefit of this method. Levine and coworkers retrospect-
ively analyzed (mean follow-up 3.75 years) 50 HHT pa-
tientsandfoundthat86%ofpatientsreportedincreased
quality of life following septodermoplasty although they
also complained about impaired sense of smell (78%),
crusting (72%), hyposmia (58%) and symptoms of sinus-
itis (30%) [126]. Harvey and coworkers reported on a
collective of 131 HHT patients who were followed up for
60 months. Overall 268 KTP laser procedures were per-
formed. In addition, 33 patients underwent SDP, which
was significantly associated with a reduced number of
laser procedures postoperatively [122]. Fiorella and
coworkers analyzed retrospectively 67 patients who re-
ceivedSDP.Again,amajorityofpatients(57/67)reported
a higher quality of life. In addition, the authors found a
significantreductionofbloodtransfusionswith12months
postoperatively compared with the 12 months period
before the operation [127]. Recently, a modification of
SDP has been performed by Lesnik. He resected the re-
maining nasal septum and then performed SDP in nine
patients. An increase of quality of life was observed as
wellasareductionoftheneedofbloodtransfusion[128].
Young's procedure
Taylor and Young introduced the method of permanent
closure of the nasal nostrils in 1961. The aim of this
procedure is to prevent dryness and traumata of the
nasalmucosatherebyreducingthefrequencyofbleeding.
Young himself reported about the problem of permanent
breathing through the mouth and re-opened the nasal
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cavity in five of his patients. Nevertheless, permanent
nasal closure may be an option in refractory cases as
suggested by several authors [129], [130], [131]. Hitch-
ings and coworkers performed a modified Young’s pro-
cedure in eight patients with sever bleeding episodes.
Complete cessation of bleeding was observed in 88% of
patients(meanfollow-up22months).Adetailedanalysis
revealed that reduction of episodes of bleeding was as-
sociated with increased quality of life which was con-
sidered even more important than permanent nasal ob-
struction [117].
Overall, SDP and Young’s procedure are options for HHT
patients with recurrent severe episodes of epistaxis re-
fractory to local therapies and laser coagulation since in
thesepatientsreductionofbleedingobviouslydetermines
quality of life more importantly than nasal obstruction.
7 Evaluation of rhinosurgical
procedures
Rhinosurgery in patients with systemic diseases may be-
come necessary to reconstruct saddle nose deformities
and nasal septal perforations. Sinus surgery plays a role
in patients with orbital and intracranial complications. In
addition, sinus surgery may be useful in some patients
to reduce sinonasal symptoms thereby improving quality
of life (Table 1).
Extendeddiagnosticismandatoryifanunderlyingsystem-
ic disease is suspected and in cases of aetiological un-
clear saddle nose deformity or nasal septal perforation
to prevent failure of rhinosurgery in such patients. Fur-
thermore, non-reflected rhinosurgery may camouflage
thesymptomssaddlenoseornasalseptalperforationas
manifestations of a yet localized systemic disease.
Thereby, the chance to prevent a potential fatal systemic
disease by early treatment could be missed or delayed
[132].
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commendations on the treatment of nasal deformities
caused by systemic diseases are based on single case
reports or case series only. Therefore, no specific
rhinosurgical techniques have been established so far.
However, according the experiences published cartilage
and bone grafts haven been implanted with success in
stable remission in patients suffering from tuberculosis
[3], leprosy [18], [19], Wegener’s granulomatosis [45],
[49], [52], [53], sarcoidosis [56] and relapsing polychon-
dritis [89], [91].
Experiences gained from these patients suggest that
traditionally-proven surgical techniques of rhinoplasty
[133], [134], [135] can also be applied in sytemic dis-
easesasfarastheunderlyingdiseasehasbeensuccess-
fullytreatedpreviously.Rhinosurgeryisperformedideally
inastateofcompleteremissionmeaningduringcomplete
absence of clinical, serologic and radiologic signs of dis-
ease. Nevertheless revision surgery has to be expected
morefrequentlycomparedtoanormalcollectiveofrhino-
plasties [53]. The question whether cartilage or bone
grafts are associated with equal outcomes has not been
answered so far since outcome also depends several
factors including stage and severity of the underlying
disease.
InWGcostalcartilagegraftswereassociatedwithabetter
transplantsuccessrate(83%)comparedwithbonegrafts
(calvarial bone graft; transplant success rate 75%) [53].
However, Shipchandler and coworkers did not observe
complications or resorption in four cases of WG and in
onecaseofsarcoidosisassociatedsaddlenosedeformity
treated by implantation of a split calvarial bone L-shaped
strut [56]. Bone grafts were advocated because of
greater availability and less resorption which, however,
is not corroborated by the studies of Congdon and
coworkers.
In general, infection and resorption is rarely observed
following implantation of autologous cartilage [136],
[137]. In addition, cartilage grafts display favourable
biomechanical properties particularly if used in the tip
area [138]. Although alloplastic materials are available
in almost unlimited amounts, usage is associated with a
high risk of infection and extrusion [139], [140], [141].
Therefore, autologous cartilage is the material of first
choice in the reconstruction of saddle nose deformities
[19], [134], [140], [142], [143]. According to the data
presentedinthisreviewthisstatementseemstobevalid
for some systemic diseases as well [3], [18], [19], [53],
[91].
Inthecaseofnasalseptalperforationcausedbysystemic
diseases recommendations on closure of perforations
are only theoretical due to missing clinical data. In gen-
eral, nasal septal perforation occurs as complication fol-
lowingseptalsurgery,traumaorbecauseofotherfactors
[48], [132], [144], [145], [146], [147]. Aside from these
factors systemic diseases can be associated with nasal
septal perforation. In many cases series and reviews
retrospectively analyzing the outcome of different tech-
niques for closure of nasal septal perforation, included
patientswerealwaysfreeofanysystemicdisease.Accord-
ingtosuchaselectionofpatientsitcanbeassumedthat
active systemic disease is a contraindication for closure
of nasal septal perforation.
Closure of asymptomatic nasal perforations is not indi-
cated. In the case of active systemic disease that cannot
be controlled implantation of a septal button is an alter-
nativeoption[146], [148]. Inthecaseofsurgicalclosure
the operation is only performed if the mucosa has been
fully rehabilitated [132], [145].
Since implanation of autologous cartilage or bone grafts
is also an important step in most multilayer techniques
forclosureofnasalseptalperforation,experiencesgained
from reconstructive surgery of saddle nose deformities
shouldbeconsidered.Itisessentialtoidentify, eliminate
or at least diminish the aetiological factor causing a
nasal septal perforation [132], [144], [145]. Provided
that there are optimal conditions the same surgical
techniques that have been proven successful in the
closure of iatrogenic or traumatic nasal septal perfora-
tions can be applied in systemic diseases. According to
our personal concept surgical approach and technique
are dependent on the localization and the size of a per-
foration (Figure 6). Small perforations (type A) can be
closed by exchange of cartilage as demonstrated in HIV
positive patient (Figure 2). Type B perforations can be
closed using bipedicled gingivobuccal flaps (Figure 7).
Larger perforations (type C) can be closed by cartilage
implant and bilateral inferior turbinate flaps as demon-
strated in a patient with WG in remission (Figure 4).
Figure6:Graduationofnasalseptalperforations.TypeA:small
perforation at the area I (<1 cm in diameter). Type B large
perforation at the areas I and II (about 1–1.5 cm in diameter).
Type C: Large perforation at the area II and III (>1.5 cm in
diameter).
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of the perforation (A). Principle of mobilization of a
gingivobuccalpedicledflap(B).Preparationofagingivobuccal
pedicled flap in vivo (C). Closure of the perforation by sutures
(D).
Ingeneral,successfulclosureofnasalseptalperforation
hasbeenobservedifamultilayertechniquewasapplied.
These techniques have the following steps in common:
a) extensive subperichondrial/periosteal dissection and
mobilization of the nasal mucosa from the remaining
septum, nasal floor and root, b) tension-free closure of
mucosal borders, c) interposition of a connective tissue
graft such as temporal muscle fascia, periosteum, cartil-
age grafts with perichondreum or a combination thereof
[48], [144], [145], [146], [149], [150].
Overall, reconstruction of nasal deformities and closure
of nasal septal perforation associated with systemic dis-
eases has to be always decided in consideration of the
type of the disease, severity of the disease, frequency of
recurrences and prognosis. Ideally, patients should be in
complete remission supported by excellent compliance
and long-term medication.
References
1. Hup AK, Haitjema T, de Kuijper G. Primary nasal tuberculosis.
Rhinology. 2001;39(1):47-8.
2. Prasad KC, Sreedharan S, Chakravarthy Y, Prasad SC.
Tuberculosisintheheadandneck:experienceinIndia.JLaryngol
Otol. 2007;121(10):979-85. DOI:
10.1017/S0022215107006913
3. Kim YM, Kim AY, Park YH, Kim DH, Rha KS. Eight cases of nasal
tuberculosis. Otolaryngol Head Neck Surg. 2007;137(3):500-4.
DOI: 10.1016/j.otohns.2007.04.009
4. Choi YC, Park YS, Jeon EJ, Song SH. The disappeared disease:
tuberculosis of the nasal septum. Rhinology. 2000;38(2):90-2.
5. Lai TY, Liu PJ, Chan LP. Primary nasal tuberculosis presenting
withseptalperforation.JFormosMedAssoc.2007;106(11):953-
5. DOI: 10.1016/S0929-6646(08)60066-2
6. Jha D, Deka RC, Sharma MC. Tuberculosis of the maxillary sinus
manifesting as a facial abscess. Ear Nose Throat J.
2002;81(2):102-4.
7. TseGM,MaTK,ChanAB,etal.Tuberculosisofthenasopharynx:
arareentityrevisited.Laryngoscope.2003;113(4):737-40.DOI:
10.1097/00005537-200304000-00027
8. Al Serhani AM. Mycobacterial infection of the head and neck:
presentation and diagnosis. Laryngoscope. 2001;111(11 Pt
1):2012-6. DOI: 10.1097/00005537-200111000-00027
9. Kapoor N, Malik R. Tuberculous nasal polyp. Indian J Pathol
Microbiol. 2003;46(2):279.
10. Hemmaoui B, Darouassi Y, Errami N, et al. Primary nasal
tuberculosis: a case report. Rev Laryngol Otol Rhinol (Bord).
2007;128(3):193-5.
11. AlicB,AskarI.Cutaneoustuberculosisonthenasaldorsum.Ann
Plast Surg. 2001;47(3):348-9. DOI: 10.1097/00000637-
200109000-00026
12. Patrocinio LG, Goulart IM, Goulart LR, Patrocinio JA, Ferreira FR,
Fleury RN. Detection of Mycobacterium leprae in nasal mucosa
biopsies by the polymerase chain reaction. FEMS Immunol Med
Microbiol. 2005;44(3):311-6. DOI:
10.1016/j.femsim.2005.01.002
13. Mishra A, Saito K, Barbash SE, Mishra N, Doty RL. Olfactory
dysfunction in leprosy. Laryngoscope. 2006;116(3):413-6. DOI:
10.1097/01.MLG.0000195001.03483.F2
14. GuptaSC,TiwariM,SinghKG.Radiologicalandantroscopicstudy
of maxillary antrum in multibacillary leprosy patients. Indian J
Lepr. 2004;76(4):305-9.
15. KirisA,KarlidagT,KocakocE,BozgeyikZ,SarsilmazM.Paranasal
sinus computed tomography findings in patients treated for
lepromatous leprosy. J Laryngol Otol. 2007;121(1):15-8. DOI:
10.1017/S0022215106002489
16. Inamadar AC, Palit A, Kulkarni NH, Guggarigoudar SP, Yelikar
BR. Nodulo-ulcerative lesions over the nose. Indian J Dermatol
Venereol Leprol. 2004;70(3):197-8.
17. Torres-LarrosaMT,Perez-PerezLJ,QuintanaGinestarMV,Torres-
PerisV,ArtazkozdelToroJJ.Nasalleprosy:impactofmultitherapy
in the morphology and physiology of the nose. Acta
Otorrinolaringol Esp. 2007;58(5):182-6.
18. Menger DJ, Fokkens WJ, Lohuis PJ, Ingels KJ, Nolst Trenite GJ.
Reconstructive surgery of the leprosy nose: a new approach. J
Plast Reconstr Aesthet Surg. 2007;60(2):152-62. DOI:
10.1016/j.bjps.2006.06.015
19. Schwarz RJ, Macdonald M. A rational approach to nasal
reconstructioninleprosy.PlastReconstrSurg.2004;114(4):876-
82. DOI: 10.1097/01.PRS.0000133029.07666.D4
20. Porter JP, Patel AA, Dewey CM, Stewart MG. Prevalence of
sinonasal symptoms in patients with HIV infection. Am J Rhinol.
1999;13(3):203-8. DOI: 10.2500/105065899781389696
21. Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV
manifestations in otolaryngology. Am J Otolaryngol.
2006;27(3):179-85. DOI: 10.1016/j.amjoto.2005.09.011
22. Parikh SL, Venkatraman G, DelGaudio JM. Invasive fungal
sinusitis: a 15-year review from a single institution. Am J Rhinol.
2004;18(2):75-81.
23. Alobid I, Bernal M, Menendez LM, et al. Sino-nasal endoscopic
surgery in fungal sinusitis. Our experience. Acta Otorrinolaringol
Esp. 2002;53(6):393-7.
24. Kuo WT, Lee TJ, Chen YL, Huang CC. Nasal septal perforation
caused by invasive fungal sinusitis. Chang Gung Med J.
2002;25(11):769-73.
25. Murphy C, Davidson TM, Jellison W, et al. Sinonasal disease and
olfactory impairment in HIV disease: endoscopic sinus surgery
andoutcomemeasures.Laryngoscope.2000;110(10Pt1):1707-
10. DOI: 10.1097/00005537-200010000-00026
11/15 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2010, Vol. 9, ISSN 1865-1011
Sachse et al.: Nasal surgery in patients with systemic disorders26. Friedman M, Landsberg R, Tanyeri H, Schults RA, Kelanic S,
CaldarelliDD.Endoscopicsinussurgeryinpatientsinfectedwith
HIV. Laryngoscope. 2000;110(10 Pt 1):1613-6. DOI:
10.1097/00005537-200010000-00006
27. Bennett AM, Patel N, Kotecha B, Al Okati A. Septal perforation
secondary to Mycobacterium kansasii infection. J Laryngol Otol.
2003;117(12):992-4. DOI: 10.1258/002221503322683939
28. Rejali SD, Simo R, Saeed AM, de Carpentier J. Acquired immune
deficiency syndrome (AIDS) presenting as a nasal septal
perforation. Rhinology. 1999;37(2):93-5.
29. Kwong YL. Natural killer-cell malignancies: diagnosis and
treatment. Leukemia. 2005;19(12):2186-94. DOI:
10.1038/sj.leu.2403955
30. Borges A, Fink J, Villablanca P, Eversole R, Lufkin R. Midline
destructive lesions of the sinonasal tract: simplified terminology
based on histopathologic criteria. Am J Neuroradiol.
2000;21(2):331-6.
31. Tigges G, Delank KW, Blasius S, Stoll W. Nasal T-cell lymphoma
as a differential diagnosis of the midline granuloma syndrome.
Laryngorhinootologie.1999;78(3):139-43.DOI:10.1055/s-2007-
996846
32. Huang WT, Chang KC, Huang GC, et al. Bone marrow that is
positive for Epstein-Barr virus encoded RNA-1 by in situ
hybridization is related with a poor prognosis in patients with
extranodal natural killer/T-cell lymphoma, nasal type.
Haematologica. 2005;90(8):1063-9.
33. Ikeda T, Kanaya T, Matsuda A et al. Clinicopathologic study of
non-Hodgkin lymphoma in sinonasal and hard palate regions in
15 Japanese cases. J Otorhinolaryngol Relat Spec.
2005;67(1):23-9. DOI: 10.1159/000084145
34. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-
cell/natural killer cell lymphoma: CT and MR imaging features
of a new clinicopathologic entity. Am J Roentgenol.
2000;174(4):1141-5.
35. Sandner A, Kosling S, Helmbold P, Winkler M, Bloching MB,
Holzhausen HJ. Primary nasal natural killer/T-cell lymphomas:
classification and clinicopathological features. HNO.
2007;55(2):93-9.
36. Guttal SS, Patil NP, Shetye AD. Prosthetic rehabilitation of a
midfacial defect resulting from lethal midline granuloma – a
clinical report. J Oral Rehabil. 2006;33(11):863-7. DOI:
10.1111/j.1365-2842.2006.01616.x
37. JennetteJC,FalkRJ,AndrassyKetal.Nomenclatureofsystemic
vasculitides:proposalofaninternationalconsensusconference.
Arthritis Rheum. 1994;37(2):187-92. DOI:
10.1002/art.1780370206
38. Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH,
Gross WL. Giant cell arteritis is more prevalent in urban than in
rural populations: results of an epidemiological study of primary
systemic vasculitides in Germany. Rheumatology.
2000;39(12):1396-402. DOI:
10.1093/rheumatology/39.12.1396
39. Ahmad I, Lee WC, Nagendran V, Wilson F, Shortridge RT.
Localised Wegener's granulomatosis in otolaryngology: a review
of six cases. J Otorhinolaryngol Relat Spec. 2000;62(3):149-55.
DOI: 10.1159/000027736
40. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of
Rheumatology 1990 criteria for the classification of Wegener's
granulomatosis. Arthritis Rheum. 1990;33(8):1101-7. DOI:
10.1002/art.1780330807
41. Paulsen JI, Rudert H. Manifestations of primary vasculitis in the
ENT region. Z Rheumatol. 2001;60(4):219-25. DOI:
10.1007/s003930170047
42. Voswinkel J, Muller A, Lamprecht P. Is PR3-ANCA formation
initiated in Wegener's granulomatosis lesions? Granulomas as
potential lymphoid tissue maintaining autoantibody production.
Ann N Y Acad Sci. 2005;1051:12-9. DOI:
10.1196/annals.1361.042
43. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE,
Kallenberg CG. Association of chronic nasal carriage of
Staphylococcus aureus and higher relapse rates in Wegener
granulomatosis. Ann Intern Med. 1994;120(1):12-7.
44. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-
associated vasculitides. Am J Med. 2004;117(1):39-50. DOI:
10.1016/j.amjmed.2004.02.030
45. Gubbels SP, Barkhuizen A, Hwang PH. Head and neck
manifestations of Wegener's granulomatosis. Otolaryngol Clin
North Am. 2003;36(4):685-705. DOI: 10.1016/S0030-
6665(03)00023-9
46. McDonald TJ, DeRemee RA. Wegener's granulomatosis.
Laryngoscope. 1983;93(2):220-31. DOI: 10.1288/00005537-
198302000-00020
47. Tami TA. Granulomatous diseases and chronic rhinosinusitis.
Otolaryngol Clin North Am. 2005;38(6):1267-78. DOI:
10.1016/j.otc.2005.08.008
48. Kridel RW. Considerations in the etiology, treatment, and repair
of septal perforations. Facial Plast Surg Clin North Am.
2004;12(4):435-50. DOI: 10.1016/j.fsc.2004.04.014
49. Sproson EL, Jones NS, Al Deiri M, Lanyon P. Lessons learnt in
themanagementofWegener'sGranulomatosis:long-termfollow-
up of 60 patients. Rhinology. 2007;45(1):63-7.
50. Cannady SB, Batra PS, Koening C, et al. Sinonasal Wegener
granulomatosis: A single-institution experience with 120 cases.
Laryngoscope. 2009;119(4):757-61. DOI: 10.1002/lary.20161
51. Rasmussen N. Management of the ear, nose, and throat
manifestations of Wegener granulomatosis: an
otorhinolaryngologist's perspective. Curr Opin Rheumatol.
2001;13(1):3-11.DOI:10.1097/00002281-200101000-00002
52. Erickson VR, Hwang PH. Wegener's granulomatosis: current
trends in diagnosis and management. Curr Opin Otolaryngol
Head Neck Surg. 2007;15(3):170-6. DOI:
10.1097/MOO.0b013e3281568b96
53. CongdonD,SherrisDA,SpecksU,McDonaldT.Long-termfollow-
up of repair of external nasal deformities in patients with
Wegener's granulomatosis. Laryngoscope. 2002;112(4):731-7.
DOI: 10.1097/00005537-200204000-00025
54. Duffy FJ Jr, Rossi RM, Pribaz JJ. Reconstruction of Wegener's
nasal deformity using bilateral facial artery musculomucosal
flaps. Plast Reconstr Surg. 1998;101(5):1330-3. DOI:
10.1097/00006534-199804050-00027
55. Nishiike S, Kato T, Nagai M, Konishi M, Sakata Y. Management
and follow-up of localized Wegener's granulomatosis: a review
of five cases. Acta Otolaryngol. 2004;124(9):1103-8. DOI:
10.1080/00016480410020310
56. Shipchandler TZ, Chung BJ, Alam DS. Saddle nose deformity
reconstruction with a split calvarial bone L-shaped strut. Arch
Facial Plast Surg. 2008;10(5):305-11. DOI:
10.1001/archfaci.10.5.305
57. Unkel C, Witzke O, Wanke I, Jahnke K, Fischer M. Wegener's
granulomatosis and orbital complications of sino-nasal origin.
Laryngorhinootologie.2007;86(7):520-3.DOI:10.1055/s-2006-
945136
58. Kwan AS, Rose GE. Lacrimal drainage surgery in Wegener's
granulomatosis. Br J Ophthalmol. 2000;84(3):329-31. DOI:
10.1136/bjo.84.3.329
12/15 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2010, Vol. 9, ISSN 1865-1011
Sachse et al.: Nasal surgery in patients with systemic disorders59. Wong RJ, Gliklich RE, Rubin PA, Goodman M. Bilateral
nasolacrimal duct obstruction managed with endoscopic
techniques.ArchOtolaryngolHeadNeckSurg.1998;124(6):703-
6.
60. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL.
Stableincidenceofprimarysystemicvasculitidesoverfiveyears:
results from the German vasculitis register. Arthritis Rheum.
2005;53(1):93-9. DOI: 10.1002/art.20928
61. de Groot K, Reinhold-Keller E. Wegener's granulomatosis and
microscopic polyangiitis. Z Rheumatol. 2009;68(1):49-64. DOI:
10.1007/s00393-008-0425-z
62. MetaxarisG,ProkopakisEP,KaratzanisAD,etal.Otolaryngologic
manifestations of small vessel vasculitis. Auris Nasus Larynx.
2002;29(4):353-6. DOI: 10.1016/S0385-8146(02)00062-7
63. Burkett PR. Sinusitis and polyarteritis nodosa. Ear Nose Throat
J. 1985;64(3):127-9.
64. Oristrell SJ, Bosch Gil JA, Valdes OM, Knobel FH. Polyarteritis
nodosa and perforation of the nasal septum. Med Clin (Barc).
1985;84(16):673-4.
65. Kokan N, Hosomi Y, Inamoto S, Ohnishi K, Tanimoto H, Nibu K.
Microscopic polyangiitis histologically confirmed by biopsy from
nasal cavity and paranasal sinuses: a case report. Rheumatol
Int. 2006;26(10):936-8. DOI: 10.1007/s00296-006-0127-2
66. BraamB,GoldschmedingR,DerksenRH,vanAsbeckBS.Clinical
thinkinganddecision-makinginpractice.Apatientwitharthritis,
skin lesions and a perforated nasal septum. Ned Tijdschr
Geneeskd. 1999;143(32):1653-8.
67. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. No
difference in the incidences of vasculitides between north and
south Germany: first results of the German vasculitis register.
Rheumatology. 2002;41(5):540-9. DOI:
10.1093/rheumatology/41.5.540
68. Masi AT, Hunder GG, Lie JT, et al. The American College of
Rheumatology 1990 criteria for the classification of Churg-
Strausssyndrome(allergicgranulomatosisandangiitis).Arthritis
Rheum.1990;33(8):1094-100.DOI:10.1002/art.1780330806
69. Srouji I, Lund V, Andrews P, Edwards C. Rhinologic symptoms
and quality-of-life in patients with Churg-Strauss syndrome
vasculitis. Am J Rhinol. 2008;22(4):406-9. DOI:
10.2500/ajr.2008.22.3204
70. Bacciu A, Bacciu S, Mercante G, et al. Ear, nose and throat
manifestations of Churg-Strauss syndrome. Acta Otolaryngol.
2006;126(5):503-9. DOI: 10.1080/00016480500437435
71. Olsen KD, Neel HB III, DeRemee RA, Weiland LH. Nasal
manifestations of allergic granulomatosis and angiitis (Churg-
Strausssyndrome).OtolaryngolHeadNeckSurg.1980;88(1):85-
9.
72. Trittel C, Moller J, Euler HH, Werner JA. Churg-Strauss syndrome.
A differential diagnosis in chronic polypoid sinusitis.
Laryngorhinootologie.1995;74(9):577-80.DOI:10.1055/s-2007-
997805
73. Scharkoff T. Epidemiology of sarcoidosis. Pneumologie.
1993;47(10):588-92.
74. Kleemann D, Nofz S, Schlottmann A, Hocker I, Stengel B.
Sinonasal sarcoidosis. HNO. 2007;55(12):956-60.
75. Zeitlin JF, Tami TA, Baughman R, Winget D. Nasal and sinus
manifestations of sarcoidosis. Am J Rhinol. 2000;14(3):157-61.
DOI: 10.2500/105065800782102753
76. deShazo RD, O'Brien MM, Justice WK, Pitcock J. Diagnostic
criteria for sarcoidosis of the sinuses. J Allergy Clin Immunol.
1999;103(5 Pt 1):789-95. DOI: 10.1016/S0091-
6749(99)70421-5
77. Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: review and
report of fifteen cases. Laryngoscope. 2004;114(11):1960-3.
DOI: 10.1097/01.mlg.0000147928.06390.db
78. Long CM, Smith TL, Loehrl TA, Komorowski RA, Toohill RJ.
Sinonasal disease in patients with sarcoidosis. Am J Rhinol.
2001;15(3):211-5. DOI: 10.2500/105065801779954157
79. ColdenDG,BusabaNY.Sarcoidosispresentingasrecurrentnasal
polyps. Otolaryngol Head Neck Surg. 2000;123(4):519-21. DOI:
10.1067/mhn.2000.106193
80. Dessouky OY. Isolated sinonasal sarcoidosis with intracranial
extension: case report. Acta Otorhinolaryngol Ital.
2008;28(6):306-8.
81. Fergie N, Jones NS, Downes RN, Bingham BJ.
Dacryocystorhinostomy in nasolacrimal duct obstruction
secondary to sarcoidosis. Orbit. 1999;18(3):217-22. DOI:
10.1076/orbi.18.3.217.2708
82. LowryTR.Sarcoidosisofnasalalaandlowerlip.OtolaryngolHead
Neck Surg. 2004;131(1):142. DOI:
10.1016/j.otohns.2004.02.026
83. Kay DJ, Har-El G. The role of endoscopic sinus surgery in chronic
sinonasal sarcoidosis. Am J Rhinol. 2001;15(4):249-54.
84. Marks SC, Goodman RS. Surgical management of nasal and
sinus sarcoidosis. Otolaryngol Head Neck Surg.
1998;118(6):856-8. DOI: 10.1016/S0194-5998(98)70282-7
85. Luthra HS. Relapsing Polychondritis. In: Klippel JH, Diepa PA,
eds. Rheumatology. 2nd ed. St. Louis: Mosby; 1998. p. 1-4.
86. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing
polychondritis: prospective study of 23 patients and a review of
the literature. Medicine (Baltimore). 1976;55(3):193-215. DOI:
10.1097/00005792-197605000-00001
87. Damiani JM, Levine HL. Relapsing polychondritis – report of ten
cases. Laryngoscope. 1979;89(6 Pt 1):929-46.
88. Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol.
2006;24(6):482-5. DOI: 10.1016/j.clindermatol.2006.07.018
89. Haug MD, Witt P, Kalbermatten FD, Rieger UM, Schaefer DJ,
PiererG.Severerespiratorydysfunctioninapatientwithrelapsing
polychondritis: should we treat the saddle nose deformity? J
Plast Reconstr Aesthet Surg. 2009;62(2):e7-10. DOI:
10.1016/j.bjps.2008.05.012
90. Torossian JM, Dumas V, Allias F, Ninet J, Beziat JL. Nasal
involvement in atrophic polychondritis: a case report. Ann Chir
Plast Esthet. 1999;44(3):262-5.
91. Bell D, Wright D, Witt PD. Durability of nasal reconstructionin an
adolescent with relapsing polychondritis treated with infliximab.
Plast Reconstr Surg. 2007;120(4):1087-8. DOI:
10.1097/01.prs.0000278184.60488.8e
92. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM,
Gabriel SE. Trends in the incidence and mortality of systemic
lupus erythematosus (1950–1992). Arthritis Rheum.
1999;42(1):46-50. DOI: 10.1002/1529-
0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2
93. Hochberg MC. Updating the American College of Rheumatology
revised criteria for the classification of systemic lupus
erythematosus. Arthritis Rheum. 1997;40(9):1725. DOI:
10.1002/art.1780400928
94. Mascarenhas R, Tellechea O, Oliveira H, Reis JP, Cordeiro M,
Migueis J. Nasal septum perforation as the presenting sign of
lupus erythematosus. Dermatol Online J. 2005;11(2):12.
95. Rahman P, Gladman DD, Urowitz MB. Nasal-septal perforation
in systemic lupus erythematosus – time for a closer look. J
Rheumatol. 1999;26(8):1854-5.
13/15 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2010, Vol. 9, ISSN 1865-1011
Sachse et al.: Nasal surgery in patients with systemic disorders96. Timmer A, Breuer-Katschinski B, Goebell H. Time trends in the
incidence and disease location of Crohn's disease 1980–1995:
a prospective analysis in an urban population in Germany.
Inflamm Bowel Dis. 1999;5(2):79-84. DOI:
10.1002/ibd.3780050203
97. Bradley PJ, Ferlito A, Devaney KO, Rinaldo A. Crohn's disease
manifesting in the head and neck. Acta Otolaryngol.
2004;124(3):237-41. DOI: 10.1080/00016480310015326
98. UlnickKM,PerkinsJ.ExtraintestinalCrohn'sdisease:casereport
and review of the literature. Ear Nose Throat J. 2001;80(2):97-
100.
99. Book DT, Smith TL, McNamar JP, Saeian K, Binion DG, Toohill
RJ.Chronicsinonasaldiseaseinpatientswithinflammatorybowel
disease. Am J Rhinol. 2003;17(2):87-90.
100. Ernst A, Preyer S, Plauth M, Jenss H. Polypoid pansinusitis in an
unusual, extra-intestinal manifestation of Crohn disease. HNO.
1993;41(1):33-6.
101. Ferjaoui M, Kooli H, Najeh D, Hajri H. Nasal localization of the
Crohn's disease. Rev Laryngol Otol Rhinol (Bord).
1999;120(5):341-2.
102. Kinnear WJ. Crohn's disease affecting the nasal mucosa. J
Otolaryngol. 1985;14(6):399-400.
103. Kriskovich MD, Kelly SM, Jackson WD. Nasal septal perforation:
arareextraintestinalmanifestationofCrohn'sdisease.EarNose
Throat J. 2000;79(7):520-3.
104. Merkonidis C, Verma S, Salam MA. Saddle nose deformity in a
patient with Crohn's disease. J Laryngol Otol. 2005;119(7):573-
6. DOI: 10.1258/0022215054352126
105. Pochon N, Dulguerov P, Widgren S. Nasal manifestations of
Crohn'sdisease.OtolaryngolHeadNeckSurg.1995;113(6):813-
5. DOI: 10.1016/S0194-5998(95)70029-3
106. VenailF,GarrelR,CorpeletD,etal.NasalinvolvementinCrohn's
disease: report of a case and diagnostic difficulties of systemic
diseases affecting the nose. Rev Laryngol Otol Rhinol (Bord).
2002;123(3):179-84.
107. Eloy P, Leruth E, Goffart Y, et al. Sinonasal involvement as a rare
extraintestinal manifestation of Crohn's disease. Eur Arch
Otorhinolaryngol. 2007;264(1):103-8. DOI: 10.1007/s00405-
006-0146-3
108. Ghandour K, Issa M. Oral Crohn's disease with late intestinal
manifestations.OralSurgOralMedOralPathol.1991;72(5):565-
7. DOI: 10.1016/0030-4220(91)90495-X
109. Sari S, Dalgic B, Yilmaz M, Poyraz A. Nasal septal perforation in
an adolescent girl with Crohn's disease: a rare extraintestinal
manifestation. Dig Dis Sci. 2007;52(5):1285-7. DOI:
10.1007/s10620-006-9584-4
110. AkikusaJD,SchneiderR.Saddlenosedeformityinapatientwith
Crohn's disease. J Laryngol Otol. 2006;120(3):253-4.
111. Kryssia RC, Henry ZB. Nasal septum perforation: rare
manifestation of Crohn's disease. Indian J Gastroenterol.
2006;25(4):214.
112. Timmer A. Epidemiologie der CED. In: Hoffmann JC, Kroesen AJ,
Klump B, eds. Chronisch entzündliche Darmerkrankungen: Das
CED-HandbuchfürKlinikundPraxis.Stuttgart,NewYork:Thieme;
2004. p. 8-19.
113. Yang PC, Liu T, Wang BQ, et al. Rhinosinusitis derived
Staphylococcal enterotoxin B possibly associates with
pathogenesisofulcerativecolitis.BMCGastroenterol.2005;5:28.
DOI: 10.1186/1471-230X-5-28
114. Bachmeyer C, Laurette F, Coutarel P, Cadranel JF, Mougeot-
Martin M. Perforation of the nasal septum in hemorrhagic
rectocolitis. Presse Med. 1996;25(38):1890.
115. Kuhnel TS, Wagner BH, Schurr CP, Strutz J. Clinical strategy in
hereditary hemorrhagic telangiectasia. Am J Rhinol.
2005;19(5):508-13.
116. Folz BJ, Tennie J, Lippert BM, Werner JA. Natural history and
control of epistaxis in a group of German patients with Rendu-
Osler-Weber disease. Rhinology. 2005;43(1):40-6.
117. Hitchings AE, Lennox PA, Lund VJ, Howard DJ. The effect of
treatment for epistaxis secondary to hereditary hemorrhagic
telangiectasia. Am J Rhinol. 2005;19(1):75-8.
118. Geisthoff UW, Schneider G, Fischinger J, Plinkert PK. Hereditary
hemorrhagictelangiectasia(Osler'sdisease).Aninterdisciplinary
challenge. HNO. 2002;50(2):114-28.
119. Sadick H, Riedel F, Oulmi J, Hormann K, Bergler WF. Argon
plasma coagulation and topically applied estriol. Long-term
resultsinthetreatmentofhereditaryhemorrhagictelangiectasia
of the nasal mucosa. HNO. 2003;51(2):118-24.
120. SadickH,NaimR,OulmiJ,HormannK,BerglerW.Plasmasurgery
and topical estriol: effects on the nasal mucosa and long-term
results in patients with Osler's disease. Otolaryngol Head Neck
Surg. 2003;129(3):233-8. DOI: 10.1016/S0194-
5998(03)00361-9
121. Shah RK, Dhingra JK, Shapshay SM. Hereditary hemorrhagic
telangiectasia: a review of 76 cases. Laryngoscope.
2002;112(5):767-73. DOI: 10.1097/00005537-200205000-
00001
122. Harvey RJ, Kanagalingam J, Lund VJ. The impact of
septodermoplasty and potassium-titanyl-phosphate (KTP) laser
therapyinthetreatmentofhereditaryhemorrhagictelangiectasia-
related epistaxis. Am J Rhinol. 2008;22(2):182-7. DOI:
10.2500/ajr.2008.22.3145
123. Elden L, Montanera W, Terbrugge K, Willinsky R, Lasjaunias P,
Charles D. Angiographic embolization for the treatment of
epistaxis: a review of 108 cases. Otolaryngol Head Neck Surg.
1994;111(1):44-50.
124. Ricci G, Molini E, Hamam M, et al. Treatment of severe epistaxis
by superselective embolization: a review of 22 cases. Rev
Laryngol Otol Rhinol (Bord). 2004;125(4):247-51.
125. Golding-Wood PH. The role of arterial ligation in intractable
epistaxis. J Laryngol Otol Suppl. 1983;8:120-2.
126. Levine CG, Ross DA, Henderson KJ, Leder SB, White RI, Jr. Long-
term complications of septal dermoplasty in patients with
hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck
Surg.2008;138(6):721-4.DOI:10.1016/j.otohns.2008.01.005
127. Fiorella ML, Ross D, Henderson KJ, White RI, Jr. Outcome of
septal dermoplasty in patients with hereditary hemorrhagic
telangiectasia. Laryngoscope. 2005;115(2):301-5. DOI:
10.1097/01.mlg.0000154754.39797.43
128. Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI
Jr. Septectomy and septal dermoplasty for the treatment of
severetransfusion-dependentepistaxisinpatientswithhereditary
hemorrhagic telangiectasia and septal perforation. Am J Rhinol.
2007;21(3):312-5. DOI: 10.2500/ajr.2007.21.3017
129. Gluckman JL, Portugal LG. Modified Young's procedure for
refractoryepistaxisduetohereditaryhemorrhagictelangiectasia.
Laryngoscope. 1994;104(9):1174-7. DOI: 10.1288/00005537-
199409000-00023
130. Hosni AA, Innes AJ. Hereditary haemorrhagic telangiectasia:
Young's procedure in the management of epistaxis. J Laryngol
Otol.1994;108(9):754-7.DOI:10.1017/S0022215100128026
131. Serrano E, Percodani J, Pessey JJ. Bilateral closure of the nasal
cavity. An original surgical technique of treatment of severe
recurrentepistaxisin Rendu-Oslerdisease.AnnOtolaryngolChir
Cervicofac. 1998;115(3):169-73.
14/15 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2010, Vol. 9, ISSN 1865-1011
Sachse et al.: Nasal surgery in patients with systemic disorders132. RomoT,III,SclafaniAP,FalkAN,ToffelPH.Agraduatedapproach
to the repair of nasal septal perforations. Plast Reconstr Surg.
1999;103(1):66-75. DOI: 10.1097/00006534-199901000-
00012
133. RettingerGA.EingriffeanderNase.In:TheissingJ,RettingerGA,
Werner JA, eds. HNO Operationslehre. Stuttgart, New York:
Thieme; 2006. p. 46.
134. Riechelmann H, Rettinger G. Three-step reconstruction of
complex saddle nose deformities. Arch Otolaryngol Head Neck
Surg. 2004;130(3):334-8. DOI: 10.1001/archotol.130.3.334
135. KastenbauerER.RekonstrutkiveChirurgieanderäußerenNase.
In: Naumann HH, ed. Kopf- und Hals-Chirurgie. Bd. 1, Teil I.
Stuttgart. New York: Thieme; 1995. p. 303.
136. Sheen JH. Secondary rhinoplasty. In: Sheen JH, ed. Plastic
surgery. Philadelphia: WB Saunders Co.; 1990. p. 189.
137. Ortiz-Monasterio F, Olmedo A, Oscoy LO. The use of cartilage
grafts in primary aesthetic rhinoplasty. Plast Reconstr Surg.
1981;67(5):597-605. DOI: 10.1097/00006534-198105000-
00003
138. Daniel RK. Rhinoplasty: septal saddle nose deformity and
composite reconstruction. Plast Reconstr Surg.
2007;119(3):1029-43. DOI:
10.1097/01.prs.0000252503.30804.5e
139. Lovice DB, Mingrone MD, Toriumi DM. Grafts amd implants in
rhinoplastyandnasalreconstruction.OtolaryngolClinNorthAm.
1999;32(1):113-41. DOI: 10.1016/S0030-6665(05)70118-3
140. Vuyk HD, Adamson PA. Biomaterials in rhinoplasty. Clin
OtolaryngolAlliedSci.1998;23(3):209-17.DOI:10.1046/j.1365-
2273.1998.00133.x
141. Godin MS, Waldman SR, Johnson CM, Jr. Nasal augmentation
using Gore-Tex. A 10-year experience. Arch Facial Plast Surg.
1999;1(2):118-21. DOI: 10.1001/archfaci.1.2.118
142. Toriumi DM. Autogenous grafts are worth the extra time. Arch
Otolaryngol Head Neck Surg. 2000;126(4):562-4.
143. Parker PJ. Grafts in rhinoplasty: alloplastic vs. autogenous. Arch
Otolaryngol Head Neck Surg. 2000;126(4):558-61.
144. Pedroza F, Patrocinio LG, Arevalo O. A review of 25-year
experience of nasal septal perforation repair. Arch Facial Plast
Surg. 2007;9(1):12-8. DOI: 10.1001/archfaci.9.1.12
145. Ribeiro JS, da Silva GS. Technical advances in the correction of
septalperforationassociatedwithclosedrhinoplasty.ArchFacial
Plast Surg. 2007;9(5):321-7. DOI: 10.1001/archfaci.9.5.321
146. GohAY,HussainSS.Differentsurgicaltreatmentsfornasalseptal
perforation and their outcomes. J Laryngol Otol.
2007;121(5):419-26. DOI: 10.1017/S002221510700566X
147. DosenLK,HayeR.Nasalseptalperforation1981–2005:changes
in etiology, gender and size. BMC Ear Nose Throat Disord.
2007;7:1. DOI: 10.1186/1472-6815-7-1
148. Cogswell LK, Goodacre TE. The management of nasoseptal
perforation. Br J Plast Surg. 2000;53(2):117-20. DOI:
10.1054/bjps.1999.3233
149. Foda HM. The one-stage rhinoplasty septal perforation repair. J
Laryngol Otol. 1999;113(8):728-33. DOI:
10.1017/S0022215100145049
150. FairbanksDN,FairbanksGR.Nasalseptalperforation:prevention
and management. Ann Plast Surg. 1980;5(6):452-9. DOI:
10.1097/00000637-198012000-00007
151. Gottschlich S, Ambrosch P, Kramkowski D, et al. Head and neck
manifestations of Wegener's granulomatosis. Rhinology.
2006;44(4):227-33.
Corresponding author:
Florian Sachse
UniversityofMünster,DepartmentofOtorhinolaryngology
Head and Neck Surgery, Kardinal von Galen Ring 10,
48149Münster,Germany,phone:+49(0)251/83-56863,
fax: +49(0)251/83-56812
sachsef@mednet.uni-muenster.de
Please cite as
Sachse F, Stoll W. Nasal surgery in patients with systemic
disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg.
2010;9:Doc02.
DOI: 10.3205/cto000066, URN: urn:nbn:de:0183-cto0000667
This article is freely available from
http://www.egms.de/en/journals/cto/2011-9/cto000066.shtml
Published: 2011-04-27
Copyright
©2011 Sachse et al. This is an Open Access article distributed under
the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You
are free: to Share — to copy, distribute and transmit the work, provided
the original author and source are credited.
15/15 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2010, Vol. 9, ISSN 1865-1011
Sachse et al.: Nasal surgery in patients with systemic disorders